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A report on the Cold Spring Harbor Laboratory 27th
annual meeting on the Biology of Genomes, held in
Cold Spring Harbor, New York, USA, 6-10 May 2014.ation is responsible for a large amount of functionalFine mapping in cis discovers substantial
functional regulatory variation
‘Biology of Genomes’ is a broad annual meeting that
showcases the year’s progress in the many subfields of
genomics. With so many talks, it is impossible to cover
all of them. However, despite the variety of subject mat-
ter, several trends recurred throughout the conference.
One result that consistently resurfaced across multiple
sessions is the ability of enlarged studies of tens of thou-
sands of individuals to move beyond linkage to genes
and finely map traits to individual regulatory polymor-
phisms. Jeffrey Barret (Wellcome Trust Sanger Institute,
Hinxton, UK) was able to identify specific genes as con-
tributors to disease by using data from 12,000 patients
in the UK10K project. Hailiang Hailiang (MIT, USA)
presented results from the inflammatory bowel disease
(IBD) consortium that allowed the identification of spe-
cific variants that contribute to IBD, and Stephen Parker
(NIH Bethesda, USA) presented the results of the on-
going FUSION study of type 2 diabetes, where a com-
bination of RNA-seq and genotyping was used to
identify muscle expression quantitative trait loci (eQTLs)
associated with different physiological stages of type 2
diabetes.
With the enormous amount of data being gener-
ated, it is logical to ask: how much functional vari-
ation is found in coding versus noncoding regions of
the genome? Alexander Gusev (Harvard University,
USA) answered this question by annotating the gen-
ome using data from Encyclopedia of DNA Elements* Correspondence: dpeer@biology.columbia.edu
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unless otherwise stated.(ENCODE) and Roadmap Epigenomics projects. He
found substantial enrichment of psychophrenia QTLs
in DNase hypersensitive sites, whereas there were es-
sentially no QTLs in intron and intergenic sites.
Together, these studies suggest that regulatory vari-
variation, and we are now capable of finding many
concrete examples in cis, where chromatin state influ-
ences the cell or organism phenotype.
Even with these massive studies, there was still no
mention of trans-QTL discoveries, suggesting that even
use of tens of thousands of individuals leaves studies
under-powered to locate distal effectors. Luke Jostins
(Wellcome Trust Centre for Human Genetics, Oxford,
UK) supported this hypothesis directly by reporting an
inability to detect trans-eQTLs despite using a model
specifically designed to detect them.Transcriptional and translational regulation
Jacob Degner (European Molecular Biology Lab,
Heidelberg, Germany) finely examined one method by
which regulatory variation can have a functional im-
pact on gene expression by using cap analysis of gene
expression (CAGE), a method that precisely identifies
transcriptional start sites (TSSs), on 80 cell lines at
three time-points. By integrating genotype informa-
tion, Degher defined promoter-shape QTLs, identify-
ing two main classes of variants: those that cause the
precise location of transcription initiation to vary at a
higher rate, and those that shift the location of tran-
scriptional initiation to a new position. It is not yet
clear how these QTLs influence expression, but it
suggests at least two mechanisms by which regulatory
variation might regulate the 5′ mRNA, which could
have downstream effects on mRNA secondary struc-
ture, splicing and stability.
Beyond transcription, there are many downstream
regulatory layers that are under genetic influence.
Protein translation and protein expression are two
such layers that received substantial attention. Alexisal. The licensee has exclusive rights to distribute this article, in any medium, for
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(University of Chicago, USA) presented two sides of
a collaboration that examines this question by com-
paring the incidence of eQTLs, ‘ribo-QTLs’ and ‘pro-
tein-QTLs’, the latter of which were measured by
comparing genotype information with ribosome profil-
ing and high-throughput ‘stable isotope labeling with
amino acids in cell culture’ (SILAC) mass spectrom-
etry. The results were heartening, showing that at
least half of the functional variation that evokes an
eQTL also associates with a protein-QTL. This indi-
cates that RNA-based analyses are capturing a sub-
stantial portion of the cell phenotype. However,
significantly, it shows the promise and importance of
protein-based technologies that are capable of gener-
ating more-representative images of cell phenotypes.
Mutations and deletions
Clustered regularly interspaced short palindromic re-
peats (CRISPRs) were one of the big stories of the past
year, bringing major improvements in the ability of sci-
entists inexpensively to achieve complete gene knock-
out disruption. Neville Sanjana (Broad Institute of
Harvard and MIT, USA) presented a genome-scale
CRISPR screen, over every gene in the genome, devel-
oped in Feng Zhang’s group (Broad Institute, USA).
They screened melanoma cell lines treated with vemura-
fenib, a highly effective late-stage melanoma drug against
which most patients eventually develop resistance. In
their screen, they identified many genes known to con-
tribute to vemurafenib resistance, as well as some new
candidates, highlighting the potential of CRISPR screens
in drug discovery.
Several other groups asked questions about what can
be learned from examining natural mutations. Michael
Stratton (The Wellcome Trust Sanger Institute, Hinxton,
UK) catalogued all the different mutation types present
in the TP53 gene across numerous tissues and cell lines
and compared the mutation types with the effects of
known mutagens. He found that over 50% of the muta-
tions could be attributed to known mutagens such as
UV light or aflatoxin and was able to identify the per-
centage of mutations that each mutagen was responsible
for. However, much of the mutation load could not be
explained by his panel, suggesting that there are novel
mechanisms of DNA mutation that have not yet been
investigated.
Minyoung Wyman (Columbia University, USA) lever-
aged mutation rates in an innovative way by comparing
the rate at which germ cells accrue two different sets of
mutations: mutations resulting from mitosis that require
cell division, and non-mitotic mutations. As germ cells
do not divide between birth and puberty, the two muta-
tion types have different rates, and the historicaldifference in these rates allowed Wyman to estimate the
average generation time throughout human history: a
slow increase from 25 to 29 years.
Computation and technology
Perhaps the most consistent message throughout the
conference was that, as data increase in magnitude, their
utility is limited by the sophistication of our computa-
tional approaches. There were several excellent presenta-
tions that highlighted this fact, perhaps none more
strongly than that of Joseph Pickrell (New York Genome
Center, USA), who showed that, by using factor analysis
to integrate multiple correlated variables, much more
informative eQTLs can be discovered and used to distin-
guish causative linkages between symptoms and comor-
bid ones caused by the same functional variant. Dana
Pe’er (Columbia University, USA) showed how integrat-
ing multiple data types improves statistical power
enough to detect novel driver mutations that are missed
by any data type alone.
Matthew Stephens (University of Chicago, USA)
reexamined the foundations of a ubiquitous statistic:
the false discovery rate (FDR). Stephens showed that
the bimodal null model using common FDR algo-
rithms has the effect of depressing the corrected P-
values output by the procedure. Therefore, we are
likely over-estimating our experiments’ false discovery
rates. Finally, Oliver Stegle (European Bioinformatics
Institute, Hinxton, UK) examined the effect of the cell
cycle on gene expression in single-cell sequencing.
Unlike bulk expression analyses, which average over a
population of cells, single-cell sequencing is very sen-
sitive to the cell cycle, and Stegle demonstrated how
an algorithm that corrects for cell-cycle stage reveals
hidden information on the stage of differentiation in
embryonic stem cells. Together, these talks demon-
strate the importance of modeling the sources of vari-
ance in biological experiments and the power of
integrative analyses to uncover biologically meaningful
phenomena obscured under any single assay.
Conclusions
Holistically, Biology of Genomes 2014 provided a broad
view into many cutting-edge projects. Promising results
were reported from many corners of genomes: for ex-
ample, large studies leveraged their improved power to
identify specific regulatory SNPs; functional variation
that affects expression corresponded to matched vari-
ation in protein expression in more than half of the
cases; some early results of genome-wide deletion
screens successfully identified genes involved in drug re-
sistance; and new computational approaches were able
to integrate multiple assays profitably to uncover a
whole greater than its parts.
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